European Journal of Pharmacology
1982-01-08
An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine.
R J Baldessarini, J L Neumeyer, A Campbell, G Sperk, V J Ram, G W Arana, N S Kula
Index: Eur. J. Pharmacol. 77(1) , 87-8, (1982)
Full Text: HTML
Abstract
Related Articles:
Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.
1982-10-01
[Neuropharmacology 21(10) , 953-61, (1982)]
Dopaminergic stimulation of oxytocin concentrations in the plasma of male and female monkeys by apomorphine and a D2 receptor agonist.
1992-09-01
[J. Clin. Endocrinol. Metab. 75(3) , 855-60, (1992)]
Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.
1982-12-01
[Neuropharmacology 21(12) , 1311-6, (1982)]
(-)-10,11-Methylenedioxy-N-propylnoraporphine, an orally effective dopamine agonist and duodenal antiulcerogen in the rat.
1983-03-25
[Eur. J. Pharmacol. 88(2-3) , 273-4, (1983)]
High-performance liquid chromatographic separation and electrochemical or spectrophotometric determination of R(-)N-n-propylnorapomorphine and R(-)10,11-methylenedioxy-N-n-propylnoraporphine in primate plasma.
[J. Chromatogr. A. 426(2) , 283-94, (1988)]